Return to Vaccination News Home Page
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
http://www.aegis.com/news/ads/2003/AD031200.html
Important note:
Information in this article was accurate in 2003. The state of the art may have
changed since the publication date.
About 10 Percent of Pakistanis
Hepatitis Carriers: Experts
Xinhua News Agency (06.12.03) - Friday, June 13, 2003
Over 10 percent of Pakistan's total population of 140 million are
hepatitis B and C
patients. This was revealed at a national consultative meeting of experts on
hepatitis, according to the local newspaper Dawn. The experts said some of these
patients do not show any hepatitis symptoms for many years and lead normal
lives. They suggested that awareness be created among the general masses by
educating them in an easily understandable language, and that hepatitis patients
be provided free or subsidized medicines. About 70 percent to 80 percent of
liver diseases are caused by the
hepatitis C virus.
The hepatitis B vaccine is available, but in Pakistan the ratio of vaccination
is very low due to poor awareness, said Mohammad Umar, a consultant
gastroenterologist.
030613
AD031200
Copyright © 2003 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. comments@aegis.org.
Return to Vaccination News Home Page
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.